Literature DB >> 28323763

Prospective Randomized Clinical Trial Investigating the Effect of the Reamer-Irrigator-Aspirator on the Volume of Embolic Load and Respiratory Function During Intramedullary Nailing of Femoral Shaft Fractures.

Jeremy A Hall1, Michael D McKee, Milena R Vicente, Zachary A Morison, Niloofar Dehghan, Christine E Schemitsch, Hans J Kreder, Brad Petrisor, Emil H Schemitsch.   

Abstract

OBJECTIVES: We sought to determine whether the use of the Reamer-Irrigator-Aspirator (RIA) device resulted in a decreased amount of fat emboli compared with standard reaming (SR) when performing intramedullary (IM) nailing of femoral shaft fractures.
DESIGN: Prospective randomized clinical trial.
SETTING: Multi-centered trial, level I trauma centers. PATIENTS/PARTICIPANTS: All eligible patients who presented to participating institutions with an isolated femoral shaft fracture amenable to fixation with antegrade IM nailing. Thirty-one patients were enrolled: nine were excluded because of technical difficulties with the transesophageal echocardiogram (TEE) recording. Therefore, the study comprised 22 patients: 11 patients randomized to the SR group and eleven patients randomized to the RIA group. INTERVENTION: Antegrade IM nailing of a femoral shaft fracture with standard reamers or the RIA device. All patients were monitored intraoperatively with a continuous TEE to assess embolic events in the right atrium. A radial arterial line was used to monitor blood gases and potential systemic effects of emboli. MAIN OUTCOME MEASURE: Duration, size, and severity of emboli as measured by TEE. The operative procedure was divided into 6 distinct stages: preoperative, reduction, guidewire passage, reaming, nail insertion, and postoperative.
RESULTS: There was no significant difference in emboli between the RIA and SR groups preoperatively, during fracture reduction, guidewire insertion, or postoperatively. Measured with a standardized scoring system, there was a modest reduction in total emboli score in the RIA group during reaming (SR 5.30 [SD; 1.81] vs. RIA 4.05 [SD; 2.19], P = 0.005) and during nail insertion (SR 5.09 [SD; 1.74] vs. RIA 4.25 [SD; 1.89], P = 0.03). We were unable to correlate this reduction with any improvement in physiologic parameters (mean arterial pressure, end-tidal CO2, O2 saturation, pH, paO2, and paCO2).
CONCLUSIONS: This study showed a modest reduction of embolic debris during the reaming and nail insertion segments of the operative procedure. We were unable to correlate this with any change in physiologic parameters. LEVEL OF EVIDENCE: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2017        PMID: 28323763     DOI: 10.1097/BOT.0000000000000744

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  4 in total

1.  Healing, nonunion, and re-operation after internal fixation of diaphyseal and distal femoral fractures: a systematic review and meta-analysis.

Authors:  Riikka E Koso; Cristina Terhoeve; R Grant Steen; Robert Zura
Journal:  Int Orthop       Date:  2018-03-08       Impact factor: 3.075

Review 2.  Complications associated using the reamer-irrigator -aspirator (RIA) system: a systematic review and meta-analysis.

Authors:  Markus Laubach; Lucas P Weimer; Felix M Bläsius; Frank Hildebrand; Philipp Kobbe; Dietmar W Hutmacher
Journal:  Arch Orthop Trauma Surg       Date:  2022-09-17       Impact factor: 2.928

3.  Reamer-Irrigator-Aspirator Multiuse Application in the Treatment of Chronic Osteomyelitis.

Authors:  Ryan T Voskuil; Brian Viscomi; Ginger E Holt; Jeremy Bruce
Journal:  J Orthop Case Rep       Date:  2019

4.  Does surgical technique influence the burden of lung metastases in patients with pathologic long bone fractures?

Authors:  Joseph K Kendal; Bryan J Heard; Annalise G Abbott; Scott W Moorman; Raghav Saini; Shannon K T Puloski; Michael J Monument
Journal:  BMC Musculoskelet Disord       Date:  2022-01-31       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.